These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7027252)

  • 21. Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis.
    Remold HG; Katz AB; Haber E; David JR
    Cell Immunol; 1970 May; 1(1):133-45. PubMed ID: 4108779
    [No Abstract]   [Full Text] [Related]  

  • 22. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
    Cameron DJ
    J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of a monoclonal antibody (1C5) to human migration inhibitory factor (MIF).
    Burmeister G; Tarcsay L; Sorg C
    Immunobiology; 1986 Jul; 171(4-5):461-74. PubMed ID: 3527953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation of immunoglobulin-bearing lymphocytes in the production of macrophage migration inhibitory factor.
    Pick E; Godny Y; Gold EF
    Eur J Immunol; 1975 Aug; 5(8):584-7. PubMed ID: 789092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon.
    Neumann C; Sorg C
    Eur J Immunol; 1978 Aug; 8(8):582-9. PubMed ID: 359337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial characterization of murine migration inhibitory factor (MIF).
    Kühner AL; David JR
    J Immunol; 1976 Jan; 116(1):140-5. PubMed ID: 1107423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of migration-inhibitory factor by a human T-lymphoblast cell line.
    Remold HG; Mednis A; Kawaguchi T; Bersch N; Golde DW
    Cell Immunol; 1983 Jun; 78(2):305-13. PubMed ID: 6345005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of human interferon-gamma-like activity from migration-inhibition factor.
    Weiser WY; Remold HG; Block LH; David JR
    Cell Immunol; 1984 Oct; 88(1):109-22. PubMed ID: 6434188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
    Kniep EM; Domzig W; Lohmann-Matthes ML; Kickhöfen B
    J Immunol; 1981 Aug; 127(2):417-22. PubMed ID: 6166671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nonspecific inhibitor of macrophage migration in cell-free ascites of rat Zajdela hepatoma. II. Biochemical characterization and purificaton.
    Fahlbusch B; Zschiesche W
    Acta Biol Med Ger; 1981; 40(6):793-800. PubMed ID: 7034428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its separation from macrophage migration inhibitory factor.
    Nagasawa H; Igarashi I; Matsumoto T; Sakurai H; Marbella C; Suzuki N
    Immunobiology; 1980 Dec; 157(4-5):307-19. PubMed ID: 7005083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical characterization of macrophage cytotoxicity factor, macrophage migration inhibitory factor, T-helper cell-replacing factor and colony-stimulating factor from culture supernatants of concanavalin A-stimulated murine spleen cells.
    Hübner L; Kniep EM; Laukel H; Sorg C; Fischer H; Gassel WD; Havemann K; Kickhöfen B; Lohmann-Matthes ML; Schimpl A; Wecker E
    Immunobiology; 1980 Jul; 157(2):169-78. PubMed ID: 6997190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. IV. Characterization of migration inhibition factor-producing lymphocytes and genetic requirements for activation.
    Moorhead JW; Murphy JW; Harvey RP; Hayes RL; Fetterhoff TJ
    Eur J Immunol; 1982 May; 12(5):431-6. PubMed ID: 7047175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. II. Production and characterization of an anti-MIF antibody.
    Fahlbusch B; Metzner G; Schumann I; Tittel R
    Biomed Biochim Acta; 1986; 45(3):371-84. PubMed ID: 3518711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-yield expression and purification of recombinant human macrophage migration inhibitory factor.
    Mozetic-Francky B; Cotic V; Ritonja A; Zerovnik E; Francky A
    Protein Expr Purif; 1997 Feb; 9(1):115-24. PubMed ID: 9116493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restorative effects of thymosin polypeptides on purified protein derivative--dependent migration inhibition factor production by the peripheral blood lymphocytes of adult thymectomized guinea pigs.
    Thurman GB; Seals C; Low TL; Goldstein AL
    J Biol Response Mod; 1984; 3(2):160-73. PubMed ID: 6374044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enhancement of MIF activity by inhibition of macrophage associated esterases.
    Remold HG
    J Immunol; 1974 Apr; 112(4):1571-7. PubMed ID: 4592606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.